168 related articles for article (PubMed ID: 9197364)
1. Fractionated dosing of cyclophosphamide for establishing long-lasting skin allograft survival, stable mixed chimerism, and intrathymic clonal deletion in mice primed with allogeneic spleen cells.
Zhang QW; Mayumi H; Umesue M; Tomita Y; Nomoto K; Yasui H
Transplantation; 1997 Jun; 63(11):1667-73. PubMed ID: 9197364
[TBL] [Abstract][Full Text] [Related]
2. Mixed chimerism, heart, and skin allograft tolerance in cyclophosphamide-induced tolerance.
Zhang QW; Tomita Y; Matsuzaki G; Yoshikawa M; Shimizu I; Nakashima Y; Sueishi K; Nomoto K; Yasui H
Transplantation; 2000 Sep; 70(6):906-16. PubMed ID: 11014644
[TBL] [Abstract][Full Text] [Related]
3. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
[TBL] [Abstract][Full Text] [Related]
4. The requirement of intrathymic mixed chimerism and clonal deletion for a long-lasting skin allograft tolerance in cyclophosphamide-induced tolerance.
Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K
Eur J Immunol; 1990 Sep; 20(9):2005-13. PubMed ID: 2209702
[TBL] [Abstract][Full Text] [Related]
5. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice.
Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Maeda T; Ando T; Nomoto K
J Immunol; 1991 Mar; 146(5):1402-9. PubMed ID: 1671578
[TBL] [Abstract][Full Text] [Related]
6. Anti-CD4 monoclonal antibody reduces the dose of cyclophosphamide required to induce tolerance to H-2 haplotype identical skin allografts in mice.
Omoto K; Nishimura Y; Nomoto K; Kong YY; Umesue M; Murakami Y; Tomita Y; Nomoto K
Immunobiology; 1996 Jan; 195(1):16-32. PubMed ID: 8852598
[TBL] [Abstract][Full Text] [Related]
7. Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Jan; 144(2):463-73. PubMed ID: 2136891
[TBL] [Abstract][Full Text] [Related]
8. Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion.
Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K
J Immunol; 1990 Sep; 145(5):1303-10. PubMed ID: 2143514
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
Nishimura Y; Mayumi H; Tomita Y; Eto M; Maeda T; Nomoto K
J Immunol; 1991 Apr; 146(8):2639-47. PubMed ID: 1707914
[TBL] [Abstract][Full Text] [Related]
10. Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens.
Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nomoto K
J Exp Med; 1990 Jan; 171(1):97-113. PubMed ID: 2136907
[TBL] [Abstract][Full Text] [Related]
11. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
Hao J; Liu J; Xie S
Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930
[TBL] [Abstract][Full Text] [Related]
12. Antibody-mediated T-cell reduction or increased levels of chimerism overcome resistance to cyclophosphamide-induced tolerance in NKT-deficient mice.
Onzuka T; Tomita Y; Okano S; Shimizu I; Yamada H; Yoshikai Y; Tominaga R
Scand J Immunol; 2010 Aug; 72(2):106-17. PubMed ID: 20618769
[TBL] [Abstract][Full Text] [Related]
13. Similarity and difference in the mechanisms of neonatally induced tolerance and cyclophosphamide-induced tolerance in mice.
Eto M; Mayumi H; Nishimura Y; Maeda T; Yoshikai Y; Nomoto K
J Immunol; 1991 Oct; 147(8):2439-46. PubMed ID: 1918974
[TBL] [Abstract][Full Text] [Related]
14. Clonal deletion and clonal anergy in allogeneic bone marrow chimeras prepared with TBI or TLI.
Salam A; Vandeputte M; Waer M
Transpl Int; 1994; 7 Suppl 1():S457-61. PubMed ID: 11271280
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced tolerance to allografts in mice. X. Augmentation of split tolerance in murine combinations disparate at both H-2 and non-H-2 antigens by the use of spleen cells from donors preimmunized with recipient antigens.
Mayumi H; Himeno K; Tokuda N; Fan JL; Nomoto K
Immunobiology; 1987 May; 174(3):274-91. PubMed ID: 3305319
[TBL] [Abstract][Full Text] [Related]
16. Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide.
Tomita Y; Yoshikawa M; Zhang QW; Shimizu I; Okano S; Iwai T; Yasui H; Nomoto K
J Immunol; 2000 Jul; 165(1):34-41. PubMed ID: 10861032
[TBL] [Abstract][Full Text] [Related]
17. The necessity of both allogeneic antigens and stem cells for cyclophosphamide-induced skin allograft tolerance in mice.
Mayumi H; Good RA
Immunobiology; 1989 Feb; 178(4-5):287-304. PubMed ID: 2565882
[TBL] [Abstract][Full Text] [Related]
18. Role of peripheral hemopoietic chimerism in achieving donor-specific tolerance in adult mice.
Maeda T; Eto M; Nishimura Y; Nomoto K; Kong YY; Nomoto K
J Immunol; 1993 Feb; 150(3):753-62. PubMed ID: 8423338
[TBL] [Abstract][Full Text] [Related]
19. Importance of intrathymic mixed chimerism for the maintenance of skin allograft tolerance across fully allogeneic antigens in mice.
Eto M; Kong YY; Uozumi J; Naito S; Nomoto K
Immunology; 1999 Mar; 96(3):440-6. PubMed ID: 10233726
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of hyporesponsiveness caused by donor-specific transfusion to allogeneic minor antigens.
Nomoto K; Kanoh K; Suzuki H; Shimura T; Kuwano H
Eur Surg Res; 2001; 33(3):217-24. PubMed ID: 11490125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
